Biologically Active Substance – Page 16

Actionable Insights Powered by AI

Biologically Active Substance
ENTITY
Functional Concept

Samsung Biologics Embarks on New Phase of Growth with Bio Campus II and ADC Services

7 months ago talkbio0Tagged Antibody-Drug Conjugates, Bio Campus II, Biological Factors, Capacity, CDMO, Contract agreement, development aspects, digital transformation, expansion, Manufacturing Organization, Plants, Samsung, Services

Samsung Biologics, Bio Campus II, Plant 5, antibody-drug conjugate (ADC) services, capacity expansion, digital transformation, contract development and manufacturing organization (CDMO)

Biologically Active Substance
ENTITY
ORG

Key Presentations at JPM25: AbbVie, UCB, WuXi Biologics Highlight Industry Trends

7 months ago talkbio0Tagged AbbVie, Biological Factors, biotech, healthcare innovation, J.P. Morgan Healthcare, JPM25, trends qualifier, UCB, WuXi

JPM25, J.P. Morgan Healthcare Conference, AbbVie, UCB, WuXi Biologics, Biotech Trends, Healthcare Innovation

Biologically Active Substance
ENTITY
Eukaryote